Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921167602> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2921167602 endingPage "539" @default.
- W2921167602 startingPage "535" @default.
- W2921167602 abstract "Purpose: The purpose of this study was to evaluate the efficacy and safety of subliminal cyclophotocoagulation using a 25% duty cycle diode laser (Supra 810, SubCyclo, Quantel Medical). Methods: This was a pilot study of patients who underwent a SubCyclo photocoagulation procedure with a 25% duty cycle, between April 2016 and April 2017 at the Glaucoma Institute of Saint Joseph Hospital of Paris. All patients presented with an evolving moderate to severe glaucoma that were resistant to previous surgical treatments or with a contraindication for filtration surgery. Laser settings were programmed as follows: power 2000 mW, “on” time 0.63 ms, “off” time 1.9 ms, and 25% duty cycle per 100 seconds to each eye. Results: A total of 44 eyes of 34 patients were treated with subliminal cyclophotocoagulation, with a mean follow-up time of 12 months. Surgical success was defined as IOP ranging 6 to 21 mm Hg or a 20% IOP reduction at the last 12 months follow-up visit. The mean age of patients was 63.83±16.2 years. The mean preoperative IOP was 32.8±11.8 mm Hg which then decreased postoperatively to 24.02±7.03 mm Hg after 1 day, 18.34±8.31 mm Hg after 1 week, 18.26±8.53 mm Hg after 1 month, 20.5±8.53 mm Hg after 3 months, 18.9±9.2 mm Hg after 6 months and 18.8±9.3 mm Hg after 12 months. Our preliminary study using Subcyclo transscleral cyclophotocoagulation with a 25% duty cycle showed a 37% IOP reduction from the baseline after 3 months with a single laser session and a 45% reduction at the last 12 months follow-up, after more than one laser session. The mean number of ocular antihypertensive medications used was 3.4±1.7 before treatment which decreased to 3.0±1.6 after treatment. No significant complications or anatomic modifications were found after subliminal cyclophotocoagulation. Conclusions: Subliminal cyclophotocoagulation with a 25% duty cycle is a safe and effective procedure for reducing IOP in cases of refractory glaucoma and seems to be safer than conventional transscleral cyclophotocoagulation." @default.
- W2921167602 created "2019-03-22" @default.
- W2921167602 creator A5027140507 @default.
- W2921167602 creator A5056675200 @default.
- W2921167602 creator A5066022777 @default.
- W2921167602 date "2019-06-01" @default.
- W2921167602 modified "2023-10-18" @default.
- W2921167602 title "Benefits of SubCyclo Laser Therapy Guided by High-frequency Ultrasound Biomicroscopy in Patients With Refractory Glaucoma" @default.
- W2921167602 cites W1564636510 @default.
- W2921167602 cites W1964112238 @default.
- W2921167602 cites W1973055280 @default.
- W2921167602 cites W2001877375 @default.
- W2921167602 cites W2007266242 @default.
- W2921167602 cites W2021854711 @default.
- W2921167602 cites W2024499548 @default.
- W2921167602 cites W2024518620 @default.
- W2921167602 cites W2057266151 @default.
- W2921167602 cites W2062926276 @default.
- W2921167602 cites W2067828192 @default.
- W2921167602 cites W2098443585 @default.
- W2921167602 cites W2101959386 @default.
- W2921167602 cites W2139559155 @default.
- W2921167602 cites W2160605010 @default.
- W2921167602 cites W2163956623 @default.
- W2921167602 cites W2167025827 @default.
- W2921167602 cites W2213081321 @default.
- W2921167602 cites W2256215227 @default.
- W2921167602 cites W2731776303 @default.
- W2921167602 doi "https://doi.org/10.1097/ijg.0000000000001230" @default.
- W2921167602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30855414" @default.
- W2921167602 hasPublicationYear "2019" @default.
- W2921167602 type Work @default.
- W2921167602 sameAs 2921167602 @default.
- W2921167602 citedByCount "5" @default.
- W2921167602 countsByYear W29211676022019 @default.
- W2921167602 countsByYear W29211676022020 @default.
- W2921167602 countsByYear W29211676022021 @default.
- W2921167602 crossrefType "journal-article" @default.
- W2921167602 hasAuthorship W2921167602A5027140507 @default.
- W2921167602 hasAuthorship W2921167602A5056675200 @default.
- W2921167602 hasAuthorship W2921167602A5066022777 @default.
- W2921167602 hasConcept C118487528 @default.
- W2921167602 hasConcept C121332964 @default.
- W2921167602 hasConcept C141071460 @default.
- W2921167602 hasConcept C142424586 @default.
- W2921167602 hasConcept C142724271 @default.
- W2921167602 hasConcept C204787440 @default.
- W2921167602 hasConcept C2776494729 @default.
- W2921167602 hasConcept C2777910003 @default.
- W2921167602 hasConcept C2778236049 @default.
- W2921167602 hasConcept C2778527774 @default.
- W2921167602 hasConcept C2781092963 @default.
- W2921167602 hasConcept C71924100 @default.
- W2921167602 hasConcept C87355193 @default.
- W2921167602 hasConceptScore W2921167602C118487528 @default.
- W2921167602 hasConceptScore W2921167602C121332964 @default.
- W2921167602 hasConceptScore W2921167602C141071460 @default.
- W2921167602 hasConceptScore W2921167602C142424586 @default.
- W2921167602 hasConceptScore W2921167602C142724271 @default.
- W2921167602 hasConceptScore W2921167602C204787440 @default.
- W2921167602 hasConceptScore W2921167602C2776494729 @default.
- W2921167602 hasConceptScore W2921167602C2777910003 @default.
- W2921167602 hasConceptScore W2921167602C2778236049 @default.
- W2921167602 hasConceptScore W2921167602C2778527774 @default.
- W2921167602 hasConceptScore W2921167602C2781092963 @default.
- W2921167602 hasConceptScore W2921167602C71924100 @default.
- W2921167602 hasConceptScore W2921167602C87355193 @default.
- W2921167602 hasIssue "6" @default.
- W2921167602 hasLocation W29211676021 @default.
- W2921167602 hasLocation W29211676022 @default.
- W2921167602 hasOpenAccess W2921167602 @default.
- W2921167602 hasPrimaryLocation W29211676021 @default.
- W2921167602 hasRelatedWork W1971004186 @default.
- W2921167602 hasRelatedWork W2015793732 @default.
- W2921167602 hasRelatedWork W2042967592 @default.
- W2921167602 hasRelatedWork W2044049238 @default.
- W2921167602 hasRelatedWork W2313189165 @default.
- W2921167602 hasRelatedWork W2419291898 @default.
- W2921167602 hasRelatedWork W2886435389 @default.
- W2921167602 hasRelatedWork W4225759404 @default.
- W2921167602 hasRelatedWork W4375861827 @default.
- W2921167602 hasRelatedWork W642445530 @default.
- W2921167602 hasVolume "28" @default.
- W2921167602 isParatext "false" @default.
- W2921167602 isRetracted "false" @default.
- W2921167602 magId "2921167602" @default.
- W2921167602 workType "article" @default.